{"id":"NCT01265849","sponsor":"CEL-SCI Corporation","briefTitle":"Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity","officialTitle":"Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-12","primaryCompletion":"2020-05-15","completion":"2020-12-04","firstPosted":"2010-12-23","resultsPosted":"2022-08-19","lastUpdate":"2022-08-19"},"enrollment":928,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Squamous Cell Carcinoma of the Oral Cavity","Squamous Cell Carcinoma of the Soft Palate"],"interventions":[{"type":"BIOLOGICAL","name":"LI","otherNames":["Multikine","Leukocyte interleukin, injection"]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"Indomethacin","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Zinc","otherNames":["Multivitamins"]},{"type":"PROCEDURE","name":"Surgery","otherNames":[]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"RADIATION","name":"Radiotherapy","otherNames":[]}],"arms":[{"label":"LI + CIZ + SOC","type":"EXPERIMENTAL"},{"label":"Standard of Care (SOC) only","type":"ACTIVE_COMPARATOR"},{"label":"LI + SOC","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to determine whether LI administered in combination with cyclophosphamide, indomethacin and zinc in a multivitamin (CIZ) combination prior to standard of care therapy (surgery followed by radiotherapy or concurrent radiochemotherapy) is safe and will increase the overall survival of subjects with previously untreated locally advanced primary squamous cell carcinoma of the oral cavity or soft palate at a median of 3 to 5 years","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From the date of treatment assignment to death or the last follow-up date. Maximum follow-up was approximately 113 months.","effectByArm":[{"arm":"LI + CIZ + SOC","deltaMin":46.3,"sd":null},{"arm":"LI + SOC","deltaMin":58.1,"sd":null},{"arm":"Standard of Care (SOC)","deltaMin":52.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.4051"},{"comp":"OG000 vs OG002","p":"0.5402"},{"comp":"OG000 vs OG002","p":"0.4128"},{"comp":"OG001 vs OG002","p":"0.7181"},{"comp":"OG001 vs OG002","p":"0.9480"},{"comp":"OG001 vs OG002","p":"0.6101"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":11},"locations":{"siteCount":102,"countries":["United States","Austria","Belarus","Bosnia and Herzegovina","Canada","Croatia","France","Hungary","India","Israel","Italy","Malaysia","Poland","Romania","Russia","Serbia","Spain","Sri Lanka","Taiwan","Thailand","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40191245"],"seeAlso":["http://www.cel-sci.com"]},"adverseEventsSummary":{"seriousAny":{"events":216,"n":383},"commonTop":["Weight decreased","Mucosal inflammation","Radiation skin injury","Anaemia","Stomatitis"]}}